JP2024542738A5 - - Google Patents
Info
- Publication number
- JP2024542738A5 JP2024542738A5 JP2024532733A JP2024532733A JP2024542738A5 JP 2024542738 A5 JP2024542738 A5 JP 2024542738A5 JP 2024532733 A JP2024532733 A JP 2024532733A JP 2024532733 A JP2024532733 A JP 2024532733A JP 2024542738 A5 JP2024542738 A5 JP 2024542738A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163284957P | 2021-12-01 | 2021-12-01 | |
| US63/284,957 | 2021-12-01 | ||
| PCT/US2022/080764 WO2023102488A2 (en) | 2021-12-01 | 2022-12-01 | Compositions and methods for treatment of pain |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024542738A JP2024542738A (ja) | 2024-11-15 |
| JPWO2023102488A5 JPWO2023102488A5 (https=) | 2025-12-08 |
| JP2024542738A5 true JP2024542738A5 (https=) | 2025-12-08 |
Family
ID=86613161
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024532733A Pending JP2024542738A (ja) | 2021-12-01 | 2022-12-01 | 疼痛の治療のための組成物及び方法 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20250109402A1 (https=) |
| EP (1) | EP4441228A2 (https=) |
| JP (1) | JP2024542738A (https=) |
| KR (1) | KR20240131349A (https=) |
| CN (1) | CN118632929A (https=) |
| AU (1) | AU2022403005A1 (https=) |
| CA (1) | CA3240948A1 (https=) |
| MX (1) | MX2024006649A (https=) |
| WO (1) | WO2023102488A2 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025108284A1 (en) * | 2023-11-20 | 2025-05-30 | Shanghai Argo Biopharmaceutical Co., Ltd. | Compositions and methods for inhibiting expression of sodium voltage-gated channel alpha subunit 9 (scn9a) |
| WO2025140551A1 (en) * | 2023-12-29 | 2025-07-03 | Neuro3 Therapeutics, Inc. | COMPOSITIONS AND METHODS FOR TREATING NaV1.7 (SCN9A) -ASSOCIATED DISORDERS |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2009033027A2 (en) * | 2007-09-05 | 2009-03-12 | Medtronic, Inc. | Suppression of scn9a gene expression and/or function for the treatment of pain |
-
2022
- 2022-12-01 KR KR1020247021912A patent/KR20240131349A/ko active Pending
- 2022-12-01 CA CA3240948A patent/CA3240948A1/en active Pending
- 2022-12-01 EP EP22902400.5A patent/EP4441228A2/en active Pending
- 2022-12-01 AU AU2022403005A patent/AU2022403005A1/en active Pending
- 2022-12-01 CN CN202280087774.5A patent/CN118632929A/zh active Pending
- 2022-12-01 US US18/714,751 patent/US20250109402A1/en active Pending
- 2022-12-01 JP JP2024532733A patent/JP2024542738A/ja active Pending
- 2022-12-01 MX MX2024006649A patent/MX2024006649A/es unknown
- 2022-12-01 WO PCT/US2022/080764 patent/WO2023102488A2/en not_active Ceased